A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice

American Association for the Advancement of Science (AAAS) - Tập 318 Số 5847 - Trang 71-76 - 2007
Katsuhiko Tabuchi1,2,3,4,5, Jacqueline Blundell1,2,3,4,5, Mark R. Etherton1,2,3,4,5, Robert E. Hammer1,2,3,4,5, Xinran Liu1,2,3,4,5, Craig M. Powell1,2,3,4,5, Thomas C. Südhof1,2,3,4,5
1Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390 USA
2Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390 USA
3Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
4Department of Neuroscience, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
5Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA

Tóm tắt

Autism spectrum disorders (ASDs) are characterized by impairments in social behaviors that are sometimes coupled to specialized cognitive abilities. A small percentage of ASD patients carry mutations in genes encoding neuroligins, which are postsynaptic cell-adhesion molecules. We introduced one of these mutations into mice: the Arg 451 →Cys 451 (R451C) substitution in neuroligin-3. R451C mutant mice showed impaired social interactions but enhanced spatial learning abilities. Unexpectedly, these behavioral changes were accompanied by an increase in inhibitory synaptic transmission with no apparent effect on excitatory synapses. Deletion of neuroligin-3, in contrast, did not cause such changes, indicating that the R451C substitution represents a gain-of-function mutation. These data suggest that increased inhibitory synaptic transmission may contribute to human ASDs and that the R451C knockin mice may be a useful model for studying autism-related behaviors.

Từ khóa


Tài liệu tham khảo

10.1016/j.conb.2007.01.009

10.1016/j.tins.2006.05.010

American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM IV (American Psychiatric Publishing Arlington VA ed. 4 2002).

10.1111/j.2044-8295.1989.tb02305.x

10.1016/j.gde.2006.04.009

10.1038/nn1765

10.1523/JNEUROSCI.1944-06.2006

10.1126/science.317.5835.190

10.1074/jbc.271.5.2676

10.1126/science.1621094

10.1016/j.neuron.2006.09.003

10.1073/pnas.96.3.1100

10.1016/j.cell.2004.11.035

10.1078/0171-9335-00410

10.1073/pnas.0405939101

10.1016/j.neuron.2005.08.026

10.1073/pnas.0502038102

10.1038/nn1837

10.1093/hmg/ddh158

10.1074/jbc.M413812200

10.1016/j.neuron.2007.05.029

10.1038/ng1136

10.1086/382137

10.1038/sj.mp.4001629

10.1523/JNEUROSCI.0468-04.2004

10.1074/jbc.M410723200

10.1038/ng1985

10.1038/ng1933

10.1034/j.1601-183X.2003.00037.x

Materials and methods are available on Science Online.

10.1023/A:1010715619091

10.1073/pnas.0506071102

10.1016/0092-8674(95)90396-8

10.1016/j.neuron.2006.09.020

10.1126/science.1099745

10.1016/j.tins.2005.08.004

10.1113/jphysiol.2004.078915

We thank I. Kornblum J. Mitchell L. Fan J. Cormier and A. Roth for technical support. Supported by grants from the National Institute of Mental Health (R37 MH52804-08 to T.C.S. and K08 MH065975-04 to C.M.P.) and from Autism Speaks (to C.M.P.).